-
Ресурс РМЭБ
Единая база данных, объединяющая электронные ресурсы вузов Казахстана
Подробнее -
-
Актуальные вопросы исследований и производства пробиотической продукции
УДК:
606:579:339.13(100)
Автор статьи:
Кушугулова А.Р.
Место работы автора:
ДГП Республиканская коллекция микроорганизмов
Название журнала:
Биотехнология. Теория и практика
Год выпуска:
2010
Номер журнала:
2
Страницы:
с.25-31
Резюме на казахском языке:
2008 жылдың м?ліметтері бойынша пробиотикалық онімнің жаһанды нарығы 15,7 миллиард доллар болды. Пробиотиктерді Жапонияда, АҚШ ж?не Европа елдерінде кеңінен қолданады. Осы шолу барысында пробиотикалық өнімдердің дүниежүзілік нарығы туралы м?ліметтер, in vitro, in vivo, сондай-ақ клиникалық зерттеулердің функционалдық ролі жөніндегі н?тижелері туралым?ліметтер берілген.
Резюме на английском языке:
According to the 2008 global market for probiotic products amounted to more than 15.7 billion dollars. The most common probiotics used in Japan, the United States and Europe. The present review presents data on the world market probiotic products shows studies in vitro, in vivo, as well as the results of clinical research on their functional role.
Список литературы:
1. Metchnikoff E. The prolongation of life: optimistic studies. London: Heinemann, 1907.
2. Global Market Review of Probiotics. Forecasts to 2013. Diet / Health Foods Market Research, 2009, 53 с.
3. Probiotic Market- Advanced Technologies and Global Market (2009 - 2014). Technology. http://www. articlesbase.com/technology-articles/
4. Sanders M.E. Overview on functional foods: emphasis on probiotic bacteria. Int Dairy J, 1998;8:341–7.
5. Havenaar R., Huis in’t Veld J.H.J. Probiotics: a general view. In: Wood BJB, ed. The lactic acid bacteria. Vol 1. The lactic acid bacteria in health and disease. New York: Elsevier, 1992:151–70.
6. Sanders M.E., Klaenhammer T.R. Invited review: the scientifi c basis of Lactobacillus acidophilus NCFM functionality as a probiotic. J Dairy Sci. - 2001. - Feb;84(2):319-31.
7. Marteau P., Vesa T., Rambaud J.C. Lactose maldigestion. In: Fuller R, ed. Probiotics 2: applications and practical aspects. London: Chapman & Hall, 1997:65–87.
8. Kim H.S., Gilliland S.E. Lactobacillus acidophilus as a dietary adjunct for milk to aid lactosedigestion in humans. J Dairy Sci, 1983;66:959–66.
9. Lin M.Y., Yen C.L., Chen S.S. Management of lactose maldigestion by consuming milk containinglactobacilli. Dig Dis Sci, 1998;43:133–7.
10. Lin M.Y., Savaiano D., Harlander S. Infl uence of nonfermented dairy products containing bacterialstarter cultures on lactose maldigestion in humans. J Dairy Sci, 1991;74:87–95.
11. Glass, Lew J.F., Gangarosa R.E., LeBaron C.W., Ho MS. Estimates of morbidity and mortalityrates for diarrheal diseases in American children. J Pediatr 1991;118:S27–33.
12. Isolauri E., Juntunen M., Rautanen T., Sillanauke P., Koivula T. A human lactobacillus strain(Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics 1991;88:90–7.
13. Raza S., Graham M., Allen J., Sultana S., Cuevas L., Harte C.A. Lactobacillus GG promotes recoveryfrom acute nonbloody diarrhea in Pakistan. Pediatr Infect Dis J 1995;14:107–11.
14. Guarino A., Canani R.B., Spagnuolo M.I., Albano F., Di Benedetto L. Oral bacterial therapy reducesthe duration of symptoms and of viral excretion in children with mild diarrhea. J Pediatr GastroenterolNutr 1997;25:516–9.
15. Saavedra J.M., Bauman N.A., Oung I., Perman J.A., Yolken R.H. Feeding of Bifi dobacterium bifi dumand Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding ofrotavirus. Lancet 1994;344:1046–9.
16. Colombel J.F., Cortot A., Neut C., Romond C. Yogurt with Bifi dobacterium longum reduceserythromycin-induced gastrointestinal effects. Lancet. 1987;ii:43.
17. Agerbaek M., Gerdes L.U., Richelsen B. Hypocholesterolaemic effect of a new fermented milkproduct in healthy middle-aged men. Eur J Clin Nutr 1995;49:346–52.
18. Bukowska H., Pieczul-Mroz J., Jastrzebska M., Chelstowski K., Naruszewicz M. Decrease infi brinogen and LDL-cholesterol levels upon supplementation of diet with Lactobacillus plantarum insubjects with moderately elevated cholesterol. Atherosclerosis 1998; 137:437–8.
19. Pool-Zobel B.L., Bertram B., Kroll M., et al. Antigenotoxic properties of lactic acid bacteria in vivoin the gastrointestinal tract of rats. Nutr Cancer 1993;20:271–81.
20. Rowland I.R. Gut microfl ora and cancer. In: Leeds R.A., Rowland I.R., eds. Gut fl ora and health—past, present and future. International Congress and Symposium Series no. 219. London: RoyalSociety of Medicine Press Ltd, 1996:19–25.Goldin B.R., Gorbach S.L. The effect of milk andLactobacillus feeding on human intestinal bacterial enzyme activity. Am J Clin Nutr 1984;33:15–8.
21. Ling, Korpela R., Mykkanen H., Salminen S., Hanninen O. Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults. J Nutr 1994;124:18–23.
22. Ishibashi N., Shimamur S. Bifi dobacteria: research and development in Japan. Food Technol 1993;47:126–35.
23. Lee Y.K., Salminen S. The coming of age of probiotics. Trends Food Sci Technol 1995;6:241–5.
24. Hamilton-Miller J.M.T., Fuller R. Probiotics panacea or nostrum. BNF Nutr Bull 1996;21:199–208.
25. Saxelin M., Ahokas M., Salminen S. Dose response on the faecal colonisation of Lactobacillus strain GG administered in two different formulations. Microb Ecol Health Dis 1993;6:119–22.
26. Dinakar P., Mistry V.V. Growth and viability of Bifi dobacterium bifi dum in cheddar cheese. J Dairy Sci 1994;77:2854–64.
27. Gardiner G., Ross R.P., Collins J.K., Fitzgerald G., Stanton C. Development of a probiotic cheddar cheese containing human-derived Lactobacillus paracasei strains. Appl Environ Microbiol 1998;64:2192–9.
28. Hilliam M. Functional foods in Europe. The World of Ingredients 1998 March/April:45–7.
29. Young J. Functional foods: strategies for successful product development. FT management report.London: Pearson Professional Publishers, 1996.
30. Casas I.A., Edens F.W., Dobrogosz W.J. In: Salminen S., von Wright A., eds. Lactic acid bacteria:microbiology and functional aspects. 2nd ed. New York: Marcel Dekker Publishers, 1998:475–518.
31. Neu The crisis in antibiotic resistance. Science 1994;257:1064–73.
32. Bengmark S. Ecological control of the gastrointestinal tract. The role of probiotic fl ora. Gut 1998;42:2–7.
33. Gonzalez S.N., Appella M.C., Romero N.C., Nader-de-Macias M.E., Oliver G. Inhibition ofenteropathogens by lactobacilli strains used in fermented milk. J Food Protect 1993;56:773–6.
34. Drago L., Gismondo M.R., Lombardi A., de Haen C., Gozzini L. Inhibition of in vitro growth ofenteropathogens by new Lactobacillus isolates of human intestinal origin. FEMS Microbiol Lett 1997; 153:455–63.
35. Hudault S., Lievin V., Bernet-Camard M.F., Servin A.L. Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection. Appl Environ Microbiol 1997;63:513–8.
36. Marteau P., Rambaud J.C. Potential of using lactic acid bacteria for therapy and immunomodulation in man. FEMS Microbiol Rev 1993;12:207–20.
37. Salminen S., Isolauri E., Salminen E. Probiotics and stabilization of the gut mucosal barrier. Asia Pac J Clin Nutr 1996;5:53–6.
38. Hata Y., Yamamoto M., Ohni M., Nakajima K., Nakamura Y., Takano T. A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am J Clin Nutr 1996;64:767–71.
39. Pouwels P.H., Leer R.J., Boersma W.J. The potential of Lactobacillus as a carrier for oral immunization: development and preliminary characterization of vector systems for targeted delivery of antigens. J Biotechnol 1996;44:183–92.
40. Gardiner G., Stanton C, Lynch PB, Collins JK, Fitzgerald G, Ross RP. Evaluation of cheddar cheese as a food carrier for delivery of a probiotic strain to the gastrointestinal tract. J Dairy Sci 1999; 82:1379–87.
41. Canganella F., Gasbarri M., Massa S., Trovatelli L.D. A microbiological investigation on probiotic preparations used for animal feeding. Microbiol Res 1996;151:167–75.
42. Fuller R. Probiotics. Soc Appl Bacteriol Symp Ser 1986;15:1S–7S.
43. Underdahl N.R., Torres-Medina A., Doster A.R. Effect of Streptococcus faecium C-68 in control ofEscherichia coli-induced diarrhea in gnotobiotic pigs. Ann J Vet Res 1982;43:2227–32.
44. Edens F.W., Parkhurst C.R., Casas I.A., Dobrogosz W.J. Principles of ex ovo competitive exclusionand in ovo administration of Lactobacillus reuteri.Poultry Sci 1997;76:179–96.
1. Metchnikoff E. The prolongation of life: optimistic studies. London: Heinemann, 1907.
2. Global Market Review of Probiotics. Forecasts to 2013. Diet / Health Foods Market Research, 2009, 53 с.
3. Probiotic Market- Advanced Technologies and Global Market (2009 - 2014). Technology. http://www. articlesbase.com/technology-articles/
4. Sanders M.E. Overview on functional foods: emphasis on probiotic bacteria. Int Dairy J, 1998;8:341–7.
5. Havenaar R., Huis in’t Veld J.H.J. Probiotics: a general view. In: Wood BJB, ed. The lactic acid bacteria. Vol 1. The lactic acid bacteria in health and disease. New York: Elsevier, 1992:151–70.
6. Sanders M.E., Klaenhammer T.R. Invited review: the scientifi c basis of Lactobacillus acidophilus NCFM functionality as a probiotic. J Dairy Sci. - 2001. - Feb;84(2):319-31.
7. Marteau P., Vesa T., Rambaud J.C. Lactose maldigestion. In: Fuller R, ed. Probiotics 2: applications and practical aspects. London: Chapman & Hall, 1997:65–87.
8. Kim H.S., Gilliland S.E. Lactobacillus acidophilus as a dietary adjunct for milk to aid lactosedigestion in humans. J Dairy Sci, 1983;66:959–66.
9. Lin M.Y., Yen C.L., Chen S.S. Management of lactose maldigestion by consuming milk containinglactobacilli. Dig Dis Sci, 1998;43:133–7.
10. Lin M.Y., Savaiano D., Harlander S. Infl uence of nonfermented dairy products containing bacterialstarter cultures on lactose maldigestion in humans. J Dairy Sci, 1991;74:87–95.
11. Glass, Lew J.F., Gangarosa R.E., LeBaron C.W., Ho MS. Estimates of morbidity and mortalityrates for diarrheal diseases in American children. J Pediatr 1991;118:S27–33.
12. Isolauri E., Juntunen M., Rautanen T., Sillanauke P., Koivula T. A human lactobacillus strain(Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics 1991;88:90–7.
13. Raza S., Graham M., Allen J., Sultana S., Cuevas L., Harte C.A. Lactobacillus GG promotes recoveryfrom acute nonbloody diarrhea in Pakistan. Pediatr Infect Dis J 1995;14:107–11.
14. Guarino A., Canani R.B., Spagnuolo M.I., Albano F., Di Benedetto L. Oral bacterial therapy reducesthe duration of symptoms and of viral excretion in children with mild diarrhea. J Pediatr GastroenterolNutr 1997;25:516–9.
15. Saavedra J.M., Bauman N.A., Oung I., Perman J.A., Yolken R.H. Feeding of Bifi dobacterium bifi dumand Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding ofrotavirus. Lancet 1994;344:1046–9.
16. Colombel J.F., Cortot A., Neut C., Romond C. Yogurt with Bifi dobacterium longum reduceserythromycin-induced gastrointestinal effects. Lancet. 1987;ii:43.
17. Agerbaek M., Gerdes L.U., Richelsen B. Hypocholesterolaemic effect of a new fermented milkproduct in healthy middle-aged men. Eur J Clin Nutr 1995;49:346–52.
18. Bukowska H., Pieczul-Mroz J., Jastrzebska M., Chelstowski K., Naruszewicz M. Decrease infi brinogen and LDL-cholesterol levels upon supplementation of diet with Lactobacillus plantarum insubjects with moderately elevated cholesterol. Atherosclerosis 1998; 137:437–8.
19. Pool-Zobel B.L., Bertram B., Kroll M., et al. Antigenotoxic properties of lactic acid bacteria in vivoin the gastrointestinal tract of rats. Nutr Cancer 1993;20:271–81.
20. Rowland I.R. Gut microfl ora and cancer. In: Leeds R.A., Rowland I.R., eds. Gut fl ora and health—past, present and future. International Congress and Symposium Series no. 219. London: RoyalSociety of Medicine Press Ltd, 1996:19–25.Goldin B.R., Gorbach S.L. The effect of milk andLactobacillus feeding on human intestinal bacterial enzyme activity. Am J Clin Nutr 1984;33:15–8.
21. Ling, Korpela R., Mykkanen H., Salminen S., Hanninen O. Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults. J Nutr 1994;124:18–23.
22. Ishibashi N., Shimamur S. Bifi dobacteria: research and development in Japan. Food Technol 1993;47:126–35.
23. Lee Y.K., Salminen S. The coming of age of probiotics. Trends Food Sci Technol 1995;6:241–5.
24. Hamilton-Miller J.M.T., Fuller R. Probiotics panacea or nostrum. BNF Nutr Bull 1996;21:199–208.
25. Saxelin M., Ahokas M., Salminen S. Dose response on the faecal colonisation of Lactobacillus strain GG administered in two different formulations. Microb Ecol Health Dis 1993;6:119–22.
26. Dinakar P., Mistry V.V. Growth and viability of Bifi dobacterium bifi dum in cheddar cheese. J Dairy Sci 1994;77:2854–64.
27. Gardiner G., Ross R.P., Collins J.K., Fitzgerald G., Stanton C. Development of a probiotic cheddar cheese containing human-derived Lactobacillus paracasei strains. Appl Environ Microbiol 1998;64:2192–9.
28. Hilliam M. Functional foods in Europe. The World of Ingredients 1998 March/April:45–7.
29. Young J. Functional foods: strategies for successful product development. FT management report.London: Pearson Professional Publishers, 1996.
30. Casas I.A., Edens F.W., Dobrogosz W.J. In: Salminen S., von Wright A., eds. Lactic acid bacteria:microbiology and functional aspects. 2nd ed. New York: Marcel Dekker Publishers, 1998:475–518.
31. Neu The crisis in antibiotic resistance. Science 1994;257:1064–73.
32. Bengmark S. Ecological control of the gastrointestinal tract. The role of probiotic fl ora. Gut 1998;42:2–7.
33. Gonzalez S.N., Appella M.C., Romero N.C., Nader-de-Macias M.E., Oliver G. Inhibition ofenteropathogens by lactobacilli strains used in fermented milk. J Food Protect 1993;56:773–6.
34. Drago L., Gismondo M.R., Lombardi A., de Haen C., Gozzini L. Inhibition of in vitro growth ofenteropathogens by new Lactobacillus isolates of human intestinal origin. FEMS Microbiol Lett 1997; 153:455–63.
35. Hudault S., Lievin V., Bernet-Camard M.F., Servin A.L. Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection. Appl Environ Microbiol 1997;63:513–8.
36. Marteau P., Rambaud J.C. Potential of using lactic acid bacteria for therapy and immunomodulation in man. FEMS Microbiol Rev 1993;12:207–20.
37. Salminen S., Isolauri E., Salminen E. Probiotics and stabilization of the gut mucosal barrier. Asia Pac J Clin Nutr 1996;5:53–6.
38. Hata Y., Yamamoto M., Ohni M., Nakajima K., Nakamura Y., Takano T. A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am J Clin Nutr 1996;64:767–71.
39. Pouwels P.H., Leer R.J., Boersma W.J. The potential of Lactobacillus as a carrier for oral immunization: development and preliminary characterization of vector systems for targeted delivery of antigens. J Biotechnol 1996;44:183–92.
40. Gardiner G., Stanton C, Lynch PB, Collins JK, Fitzgerald G, Ross RP. Evaluation of cheddar cheese as a food carrier for delivery of a probiotic strain to the gastrointestinal tract. J Dairy Sci 1999; 82:1379–87.
41. Canganella F., Gasbarri M., Massa S., Trovatelli L.D. A microbiological investigation on probiotic preparations used for animal feeding. Microbiol Res 1996;151:167–75.
42. Fuller R. Probiotics. Soc Appl Bacteriol Symp Ser 1986;15:1S–7S.
43. Underdahl N.R., Torres-Medina A., Doster A.R. Effect of Streptococcus faecium C-68 in control ofEscherichia coli-induced diarrhea in gnotobiotic pigs. Ann J Vet Res 1982;43:2227–32.
44. Edens F.W., Parkhurst C.R., Casas I.A., Dobrogosz W.J. Principles of ex ovo competitive exclusionand in ovo administration of Lactobacillus reuteri.Poultry Sci 1997;76:179–96.
Электронный вариант:
скачать
Последние Новости
- 28.11.2012
Казахстанская общенациональная пробная подписка на IEEE/IET
- 20.12.2011
В шаге от цели «Smart»
- 20.12.2011
Инновационный прорыв региона